BillionToOne, Inc. Class A Common Stock (BLLN) Stock Price
BLLNStock
$100.08
Market Cap$4.72B
P/E595.31x
PEG Ratio—
Div yield—
Beta0.07
BLLN Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-3.30%
Price vs S&P 500 (4W)-30.66%
VGM Score25.14
P/E Ratio (Annual)595.31x
BLLN Earnings Surprise History
Q3 250.91est. 0.16
Q4 250.15est. 0.17
Q2 260.36est. 0.16
BLLN Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.21
4.21
4.21
4.21
Industry Peers — Health Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BLLNBillionToOne, Inc. Class A Common Stock | F | F | C | $100.08 |
| NTRANatera, Inc. Common Stock | F | A | A | $336.71 |
| LHLabcorp Holdings Inc. | C | D | B | $337.68 |
| DGXQuest Diagnostics Inc. | C | D | B | $244.51 |
| GHGuardant Health, Inc. Common Stock | F | A | A | $164.92 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | B | $28.01 |
| RDNTRadNet, Inc. Common Stock | D | C | C | $76.86 |
| CELCCelcuity Inc. Common Stock | — | — | D | $92.27 |
| GRALGRAIL, Inc. Common Stock | D | A | B | $82.54 |
| VCYTVeracyte, Inc. | D | A | C | $44.04 |
| CDNACareDx, Inc. | D | B | A | $50.80 |
About BillionToOne, Inc. Class A Common Stock
BillionToOne Inc develops precision diagnostic tests using its proprietary Quantitative Counting Templates technology to enable ultrasensitive DNA analysis. The company offers non-invasive prenatal screening and cancer monitoring solutions designed to provide greater accuracy and cost-effectiveness than traditional genetic testing. BillionToOne serves two large markets—prenatal screening and oncology—where demand for improved diagnostics continues to grow.